Goodness Growth today announced the reorganization of several executive roles and responsibilities, each of which are effective immediately. The company said the changes result in a more decentralized organizational structure which gives state-level operating teams greater flexibility to implement market-specific strategies in order to drive improved operations and financial performance.
Josh Rosen has been promoted to the role of Chief Executive Officer on an interim basis. Company founder, Dr. Kyle Kingsley, will assume the role of Executive Chairman. Chief Administrative Officer Amber Shimpa has been promoted to the role of President of the Company and CEO of subsidiary Vireo Health of Minnesota.
“Josh has been an invaluable member of our organization throughout the course of his tenure on our board and most recently in his role as Interim President. We believe he is uniquely suited to lead the Company’s transformation as Interim CEO. Our Company was built on a proud foundation of medical and scientific leadership, but our industry is evolving with great complexity, and we believe Josh’s experience and leadership will be instrumental in shaping our business with a more precise focus on localized operational excellence and disciplined capital allocation," said Kingsley.
“I have always believed that the Goodness Growth and Vireo teams have the potential to become true leaders in the future of this industry, with their medical heritage and geographically attractive operations. I’m pleased with my initial two months of intense work and look forward to helping the Company seize the opportunities in front of it. US cannabis companies are continuing to operate within many challenging environments and our team has taken considerable measures recently to better position ourselves for the future. Some of these changes required difficult decisions that impacted our workforce in New York and our home state of Minnesota, resulting in a leaner, more cohesive corporate team," said Rosen.
“I’m proud to lead Vireo Health of Minnesota into the future, and look forward to working more closely with our team members and partner organizations to improve the lives of patients and other Minnesotans who have been negatively impacted by the failed war on drugs. Our teams have identified several focus areas that will be critical for us to execute upon successfully this year, and we look forward to discussing those initiatives in more detail on our upcoming fourth-quarter and year-end results conference call next month," said Shimpa.